18
mln18
mlnCVD Deaths / Year in World
4.5
mln4.5
mlnCVD Deaths / Year in Europe
What is Megah?
Megah is a predictive approach product/process whose protocol can reduce the risk of adverse cardiovascular events by up to 2%, particularly in asymptomatic individuals. It predicts the non-occurrence of adverse events over the next 5 years. The product process applied in Predictive Cardiology utilizes artificial intelligence (AI) and big data algorithms to enhance the prevention and diagnosis of cardiovascular diseases (CVD). This system integrates advanced imaging diagnostic technologies and is capable of providing highly accurate and reliable personalized cardiovascular risk assessments.
Why MEGAH Predictive Cardiology?
Cardiovascular diseases are the leading cause of death globally, with significant healthcare costs. Current diagnostic standards lack predictive capability to identify adverse events preventively and they have a prevention reliability of only 60%. During a coronary angiography you can experience allergic reactions, bleeding or hematomas, damage to blood vessels, and in rare cases also myocardial infarction can occur. But, why is Megah Predictive Cardiology better?
- Predictive reliability of 98%
- No risk of complications during the checkup.
- Non-invasive method
- Megah Check Up = 1h
WHAT CAN MEGAH DO?
WHY CHOOSE US
Only the Megah® PREDICTIVE Check can reduce the risk of adverse cardiovascular events in asymptomatic individuals to 2%, offering a GUARANTEE of absence of adverse events for the next 5 years.
SDC
MYOCARDIAL INFARCTION
Megah can prevent heart attack, which occurs when blood flow to a part of the heart is blocked long enough to cause significant and potentially irreversible damage to the heart muscle.
CONGENITAL CARDIOVASCULAR MALFORMATIONS
Congenital cardiovascular malformations are anomalies of the heart and blood vessels present at birth. They can range from mild to severe and affect blood flow. Early diagnosis and treatment are essential for management.
RUPTURE OF THORACIC AND ABDOMINAL AORTIC ANEURYSMS
Megah can prevent rapture of thoracic and abdominal aortic aneurysms, which is a sudden, life-threatening break in the wall of the aorta in the chest or abdomen, leading to severe internal bleeding and a high risk of death.
LUNG TUMOR AND VASCULOPATHY FROM COVID
Lung cancer is a neoplasm that affects lung tissues, often associated with smoking. COVID-related vasculopathies can cause inflammation and damage to blood vessels, contributing to cardiovascular complications.
Get In Touch With Us
We’d love to hear from you! If you have any questions or need assistance, please don’t hesitate to reach out and send us a message—our friendly team is here to provide the support and answers you need.
See Our Latest Blog
Technological revolution
The cardiovascular process involves early identification and management of atherosclerosis, influenced by modifiable and non-modifiable risk factors, including genetic predisposition, age, sex, smoking, hypertension, blood cholesterol, and diabetes, in order to prevent damage in the later stages of heart disease.
Cardiovascular Process
The cardiovascular process involves the early identification and management of atherosclerosis, which is influenced by both modifiable and non-modifiable risk factors, including genetic predispositions, age, gender, smoking, high blood pressure, cholesterol levels, and diabetes, to prevent advanced-stage damage.